Jaguar Health, Inc. (JAGX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Jaguar Health, Inc. reported revenue of $11.51M, down 1.5% from the prior year. The company ran a net loss, with a net margin of -465.4%. It held $38.32M in total assets against $57.01M in total liabilities.
Key ratios (FY2025)
-398.8%
Operating margin
-465.4%
Net margin
-1.5%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.51M | $11.69M | $9.76M | $11.96M | $4.33M | $9.38M | $5.78M | $4.42M | $4.36M | $141.5K |
| Cost of Revenue | $3.77M | $1.96M | $2.04M | $2.02M | $2.33M | $3.28M | $3.82M | $2.77M | $880.4K | $52.0K |
| Operating Income | -$45.91M | -$30.83M | -$34.29M | -$34.41M | -$40.71M | -$26.65M | -$28.95M | -$30.82M | -$34.25M | -$13.59M |
| Net Income | -$53.58M | -$38.49M | -$41.9K | -$48.4K | -$52.6K | -$33.81M | -$38.54M | -$32.15M | -$21.97M | -$14.73M |
| EPS (Diluted) | $-22.97 | $-130.69 | $-2678.17 | $-36.18 | $-88.22 | $-3.00 | — | — | — | — |
| Total Assets | $38.32M | $53.42M | $50.76M | $47.45M | $53.27M | $42.84M | $36.41M | $41.04M | $43.63M | $3.56M |
| Total Liabilities | $57.01M | $44.45M | $45.87M | $48.81M | $41.41M | $25.64M | $15.84M | $26.66M | $26.37M | $6.02M |
| Shareholders' Equity | -$18.69M | $6.49M | $4.90M | -$1.36M | $11.85M | $17.20M | $10.67M | — | — | — |
| Cash & Equivalents | $968.0K | $8.00M | $6.47M | $5.47M | $17.05M | $8.09M | $3.50M | $2.57M | $520.7K | $951.0K |
| Operating Cash Flow | -$23.69M | -$29.38M | -$33.24M | -$33.10M | -$34.97M | -$15.28M | -$20.46M | -$22.73M | -$9.82M | -$14.41M |
| Capital Expenditures | — | $16.0K | — | $77.0K | $6.0K | $7.0K | — | $6.5K | — | $104.2K |
| Shares Outstanding | 2.33M | 294.5K | 15.4K | 1.31M | 596.2K | 12.88M | — | — | — | — |